Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

830
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
830
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.2K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

576
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
576
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacometabolomics of treatment response to antihypertensive drugs: a systematic review.

Journal of hypertension·2026
Same author

Stratifying prognosis in heart failure patients with reduced ejection fraction and atrial cardiomyopathy.

ESC heart failure·2026
Same author

Fourier-Net+: Band-Limited Spatial Representation for Efficient Medical Image Registration.

IEEE transactions on neural networks and learning systems·2026
Same author

What factors are associated with work after cardiothoracic transplant? A systematic review.

Transplantation reviews (Orlando, Fla.)·2026
Same author

Cognitive Decline Preceding Incident Cardiovascular Events in Older Adults.

JAMA network open·2026
Same author

Associations between Cardiovascular Risk Factors and Cognitive Function: A Cross-Sectional Study of Twins in the UK.

Gerontology·2026

Related Experiment Video

Updated: Mar 26, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.2K

Comorbidities in Heart Failure: Are There Gender Differences?

Ingrid Hopper1,2, Dipak Kotecha3,4, Ken Lee Chin5,6

  • 1Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia. ingrid.hopper@monash.edu.

Current Heart Failure Reports
|February 3, 2016
PubMed
Summary

Women with heart failure (HF) often have different comorbidities than men, impacting their quality of life. Understanding these gender differences in non-cardiovascular conditions is key to personalizing HF treatment and improving patient outcomes.

Keywords:
AnemiaArthritisCOPDComorbidityDiabetesEjection fractionHeart failureRenal dysfunction

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

765
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

3.0K

Related Experiment Videos

Last Updated: Mar 26, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.2K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

765
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

3.0K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Women with heart failure (HF) present differently than men, often older, with preserved ejection fraction (EF) and hypertensive HF.
  • Women are underrepresented in HF clinical trials, limiting gender-specific outcome data.
  • Despite potentially better survival, women report lower quality of life and greater functional impairment due to HF.

Purpose of the Study:

  • To review and explore evidence on gender differences in non-cardiovascular comorbidities in heart failure patients.
  • To identify how comorbidities may contribute to gender disparities in HF outcomes.
  • To inform individualized HF care strategies for better prognosis.

Main Methods:

  • Literature review focusing on gender differences in HF comorbidities.
  • Analysis of existing data on comorbidities in male and female HF populations.
  • Examination of potential confounding factors like EF and medical therapy utilization.

Main Results:

  • Significant gender differences exist in comorbidities such as diabetes, COPD, renal dysfunction, anemia, and depression in HF patients.
  • These comorbidities may partially explain outcome disparities between genders.
  • Confounding by prognostic determinants (e.g., EF) and treatment variations complicates direct interpretation.

Conclusions:

  • Gender disparities in non-cardiovascular comorbidities are evident in heart failure.
  • Individualizing HF care based on gender-specific comorbidity profiles is crucial.
  • Further research is needed to clarify the interplay between gender, comorbidities, and HF outcomes.